There is emerging evidence that suggests the importance of the liver in sepsis patients who are at risk of developing subsequent pneumonia. This is the first report directly demonstrating a link between a key mediator produced by the liver and how the body responds to an infection.
A new biomarker for an aggressive subtype of breast cancer has been identified, which may also be a potential therapeutic target.
A new imaging tool developed by BUSM’s Narayanan “Bobby” Kasthuri, MD, an assistant professor in the department of anatomy and neurobiology, could do for the brain what the telescope did for space exploration.
BUSM’s David Felson, MD, has received a $6 million renewal for Multicenter Osteoarthritis Study
Beginning September 14, Linda Hyman, PhD, Associate Provost for Graduate Medical Sciences (GMS), will be ‘on loan’ to the National Science Foundation (NSF) to serve as Director of the Division of Molecular and Cellular Biosciences. The Division comprises the areas of molecular biophysics, cellular dynamics and functions, genetic mechanisms and systems, and synthetic biology. Her […]
BUSM researchers Ganem and Singh, assistant professors of pharmacology & experimental therapeutics, have each received Jackie King Young Investigator Awards from the Melanoma Research Alliance.
More than 100 faculty, staff, residents and students attended the 10th annual John McCahan Medical Education Day.
Scientists presented on how they have utilized FHS data to answer career-building questions.
A major treatment breakthrough for scleroderma may soon be available for the estimated 300,000 Americans who suffer with this condition.
Joseph Mizgerd, ScD, professor of medicine, microbiology and biochemistry at Boston University School of Medicine (BUSM), and director of the University’s Pulmonary Center, recently was awarded $1.6 million from the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The four-year grant will be used to fund his project to better […]